From Blueprint Medicines Brings In $40M, Led by Third Rock, for Targeted Cancer Therapies:

Blueprint Medicines
Blueprint Medicines

Blueprint Medicines, a Cambridge, MA-based biotech startup incubated by Third Rock Ventures, focused on developing personalized cancer therapies